Stay updated on Nivolumab & Brentuximab in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Brentuximab in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Brentuximab in Lymphoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    Change Detected
    Summary
    The study has expanded to include 27 locations and has been updated from Revision v2.9.7 to v2.10.0.
    Difference
    0.3%
    Check dated 2024-07-23T14:25:25.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T07:43:11.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T13:48:11.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-27T09:51:29.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-26T08:39:46.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value 'Show more Revision: v2.9.0' has been updated to 'MedlinePlus related topics: Lymphoma Genetic and Rare Diseases Information Center resources: Lymphosarcoma Drug Information available for: Brentuximab vedotin Nivolumab FDA Drug and Device Resources'. This change reflects additional information related to Lymphoma and resources available for Brentuximab vedotin and Nivolumab.
    Difference
    87%
    Check dated 2024-06-25T08:19:43.000Z thumbnail image

Stay in the know with updates to Nivolumab & Brentuximab in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Brentuximab in Lymphoma Clinical Trial page.